bevacizumab,sintilimab
eli lilly,innovent biologics,etana
['sintilimab', 'lcsm,(-blcsm)', 'orient-31', 'nsclc', 'sclc']
sintilimab +/- ibi305 + chemotherapy in patients with egfr mutated nsclc) who progressed on egfr tyrosine-kinase inhibitors. second interim analysis of phase ill orient-31 study. positive for pfs in sintilimab arm vs chemo alone. os data immature yet. #esmo22 #lcsm 
Medical Oncology ?? HGU Gregorio Marañón?@myESMO Faculty ?? Lung Cancer - Mesothelioma - Thymoma?Power to the patients #endlungcancer #lcsm